NewsDialy
The Chan Zuckerberg Initiative's Biohub is opening a new funding round aimed at the rare disease community while simultaneously expanding its artificial intelligence drug repurposing partnership with Every Cure.
The move signals a broadening commitment by one of philanthropy's best-resourced science programs to a corner of medicine where commercial incentives alone have long fallen short.
What Drug Repurposing Is and Why It Changes the Math Drug repurposing means finding new therapeutic uses for medicines that are already approved — essentially asking whether a drug developed for one disease might work against another.
For rare diseases, this approach carries particular weight.
Keep reading